Vimarsana
Biggest News Aggregation in the World

Page 16 - Foreign Labor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Foreign Labor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Foreign Labor Today - Breaking & Trending Today

How much does Postmates pay engineers, data scientists? - Vimarsana News

How much does Postmates pay engineers, data scientists?

An analysis of Postmates salaries reveals they are competitive with Google and Amazon when it comes to paying tech-level engineers.

Roku US salaries revealed for product, engineer, manager jobs - Vimarsana News

Roku US salaries revealed for product, engineer, manager jobs

Roku ramped up hiring during the year as its market cap climbed, recent research shows. Business Insider also analyzed US work-visa disclosure data released by the US Office of Foreign Labor Certification to gauge how much Roku offered to pay for certain roles, including product, engineering, and manager jobs. Based on the data, Roku offered staffers on work visas in the US annual base salaries between $108,000 to $638,000 during the year that ended Sept. 30. Roku ramped up hiring during the year as its market cap climbed, recent research shows. The number of active job listings from Roku ros...

Your COVID-19 Vaccine Was Likely Made by an Immigrant - Vimarsana News

Your COVID-19 Vaccine Was Likely Made by an Immigrant

Your COVID-19 Vaccine Was Likely Made by an Immigrant The development of a COVID-19 vaccine is a global endeavor. The scientists and entrepreneurs creating the vaccine are of many nationalities and immigration statuses—as are the millions of people impacted by the pandemic who are anxiously awaiting a vaccine. The three pharmaceutical companies with vaccines near-ready for distribution—BioNTech, Pfizer, and Moderna—were all founded by immigrants. Consider the partnership between the German company BioNTech SE and the American company Pfizer Inc., which has now completed a working vaccin...